REQUEST A DEMO
Total
USD $0.00
Search more companies

Vivax Pharmaceuticals, S.R.O. (Slovakia)

Main Activities: Administrative Management and General Management Consulting Services
Full name: Vivax Pharmaceuticals, S.R.O. Profile Updated: October 10, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Vivax Pharmaceuticals, S.R.O. is an enterprise in Slovakia, with the main office in Povazska Bystrica. It operates in the Administrative Management and General Management Consulting Services sector. The company was established on July 17, 1996. 5 - 9 (2023) employees currently work for Vivax Pharmaceuticals, S.R.O.. The company’s latest financial report indicates a net sales revenue drop of 17.07% in 2023. Its’ total assets recorded a negative growth of 15.61%. In 2023, Vivax Pharmaceuticals, S.R.O.’s net profit margin decreased by 1.93%.

Headquarters
Moyzesova, 868/67
Povazska Bystrica; Trenciansky; Postal Code: 01701

Contact Details: Purchase the Vivax Pharmaceuticals, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Vivax Pharmaceuticals, S.R.O. report to view the information.
Outstanding Shares:
Purchase the Vivax Pharmaceuticals, S.R.O. report to view the information.
Registered Capital:
Purchase the Vivax Pharmaceuticals, S.R.O. report to view the information.
Incorporation Date:
July 17, 1996
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
56.67%
Purchase this report to view the information.
21.67%
Purchase this report to view the information.
21.67%
Company Performance
Financial values in the chart are available after Vivax Pharmaceuticals, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-17.07%
Total operating revenue
-17.07%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
-97.79%
Total assets
-15.61%
Total equity
-19.71%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-1.93%
Return on Equity (ROE)
-7.84%
Debt to Equity Ratio
10.23%
Quick Ratio
0.07%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?